DocGo Inc. (DCGO) 주식 분석
의료DocGo Inc.
$0.63
$-0.00 (-0.08%)
최종 업데이트: 2026년 5월 26일
가격 추이
가격 데이터가 없습니다
분석
회사 개요
DocGo Inc. operates as a specialized mobile healthcare services provider serving markets within the United States and the United Kingdom, delivering essential medical transportation and emergency response capabilities. The company functions within the Healthcare sector, specifically categorized under the Medical Care Facilities industry, which signifies its critical role in facilitating patient access to medical care through logistics and operational support. Its organizational scale is defined by a market capitalization of $56.96M, an annual revenue of $322.20M, and a workforce comprising 2,537 employees. These valuation and revenue figures indicate that the company operates as a mid-sized entity with significant operational reach, yet its relatively modest market cap relative to its revenue suggests a specific market positioning or investor sentiment distinct from larger peers in the broader healthcare infrastructure space.
재무 건전성
The company reported a trailing twelve-month revenue of $322.20M against a net income of -$182.39M and an EBITDA of -$73.50M, revealing a substantial gap between top-line generation and bottom-line profitability that points to a challenging cost structure or significant operational expenses not fully covered by gross margins. Despite the negative net income, the entity maintains a free cash flow of $56.60M, which provides a degree of financial flexibility by indicating that cash generation from operations exceeds capital expenditures and working capital requirements. The margin profile shows a gross margin of 30.7%, contrasting sharply with an operating margin of -43.3% and a profit margin of -56.6%, which highlights that while the core service delivery retains value, overhead costs and other operating expenses are eroding profitability to a severe degree. On the balance sheet, the company holds $51.02M in cash against $29.18M in debt, supported by a debt-to-equity ratio of 23.18, suggesting a leveraged position where debt obligations are significant relative to shareholder equity. Liquidity is supported by a current ratio of 2.26, indicating that current assets are more than double current liabilities and providing a buffer for short-term obligations. Return metrics reflect this financial pressure with a return on equity of -89.0% and a return on assets of -16.6%, demonstrating that management effectiveness in generating returns for shareholders and utilizing asset base has been negative over the trailing period.
밸류에이션 평가
Valuation multiples present a complex picture with a trailing P/E ratio listed as N/A due to the negative earnings, while the forward P/E stands at 3.30, implying expectations of future earnings normalization or a specific accounting treatment for upcoming periods. The price-to-book ratio is recorded at 0.40, indicating that the market values the company at a significant discount to its book value, which often signals potential distress or a perceived lack of growth prospects relative to asset holdings. Alternative valuation metrics further illustrate this discount, with a price-to-sales ratio of 0.18 and an EV/EBITDA of -0.23, suggesting that traditional earnings-based valuation is not applicable and price is driven by revenue or asset considerations rather than profitability. Price momentum is constrained between a 52-week high of $2.65 and a 52-week low of $0.53, with the current trading price situated well below the 52-week high, reflecting the market's current skepticism regarding the asset's short-term upside. The stock exhibits a beta of 0.98, meaning its price volatility tracks the broader market closely without significant amplification or dampening of market movements.
Growth & Income
Revenue growth year-over-year stands at -38.0%, while earnings growth is N/A due to the absence of positive earnings in the comparable period, indicating that the company is currently in a contractionary phase rather than an expansionary one. The company does not distribute dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which implies that all available cash flow is retained for operational continuity, debt servicing, or potential restructuring rather than shareholder distribution. The absence of a dividend payout is consistent with the negative net income and negative return on equity, as distributing cash would be financially unsustainable given the current operating losses. Overall, the growth and income profile characterizes DocGo Inc. as a firm currently prioritizing survival and cost management over revenue expansion or income generation for investors.
동종업체 비교
DocGo Inc. (DCGO) 은(는) 의료 시설 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:
| 기업명 | 티커 | 시가총액 | PER |
|---|---|---|---|
| DocGo Inc. | DCGO | $62.23M | N/A |
| HCA Healthcare, Inc. | HCA | $87.05B | 13.5 |
| Tenet Healthcare Corporation | THC | $15.19B | 9.2 |
| DaVita Inc. | DVA | $12.55B | 18.8 |
의료 시설 산업 평균 PER은 28.6배입니다. DocGo Inc.의 PER은 N/A입니다.
이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.
관련 의료 시설 종목
HCA Healthcare, Inc.
$87.05B
THCTenet Healthcare Corporation
$15.19B
DVADaVita Inc.
$12.55B
FMSFresenius Medical Care AG
$11.59B
EHCEncompass Health Corporation
$10.41B
ENSGThe Ensign Group, Inc.
$10.08B
의료 인기 주식
Eli Lilly and Company
$949.47B
JNJJohnson & Johnson
$554.09B
ABBVAbbVie Inc.
$376.54B
UNHUnitedHealth Group Incorporated
$342.24B
MRKMerck & Co., Inc.
$302.33B
DocGo Inc. 소개
DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
회사 설명은 영어로 표시됩니다.
웹사이트 방문 →